170 related articles for article (PubMed ID: 33168091)
21. Single-cell transcriptome and genome analysis: A much-needed tool for pituitary neuroendocrine tumor studies.
Asa SL; Mete O
Neuro Oncol; 2021 Nov; 23(11):1803-1804. PubMed ID: 34480475
[No Abstract] [Full Text] [Related]
22. Phenotype Transformation of PitNETs.
Li Z; Wu Y; He G; Wang R; Bao X
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730682
[TBL] [Abstract][Full Text] [Related]
23. Editorial: Pituitary neuroendocrine tumors: tumorigenesis, pathogenesis, diagnosis and targeted therapy, from bench to bedside.
Lyu H; Li L; Yang YR; Yao Y; Wang H; Huang GD
Front Neurosci; 2024; 18():1358700. PubMed ID: 38495108
[No Abstract] [Full Text] [Related]
24. USP8 and TP53 Drivers are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors.
Uzilov AV; Taik P; Cheesman KC; Javanmard P; Ying K; Roehnelt A; Wang H; Fink MY; Lau CY; Moe AS; Villar J; Bederson JB; Stewart AF; Donovan MJ; Mahajan M; Sebra R; Post KD; Chen R; Geer EB
J Clin Endocrinol Metab; 2021 Mar; 106(3):826-842. PubMed ID: 33221858
[TBL] [Abstract][Full Text] [Related]
25. Classification of neuroendocrine neoplasms: lights and shadows.
La Rosa S; Uccella S
Rev Endocr Metab Disord; 2021 Sep; 22(3):527-538. PubMed ID: 33169199
[TBL] [Abstract][Full Text] [Related]
26. Favorable response to immunotherapy in a pancreatic neuroendocrine tumor with temozolomide-induced high tumor mutational burden.
Cao Y; Ma Y; Yu J; Sun Y; Sun T; Shao Y; Li J; Shen L; Lu M
Cancer Commun (Lond); 2020 Dec; 40(12):746-751. PubMed ID: 33230973
[TBL] [Abstract][Full Text] [Related]
27. Distinctive features of pancreatic neuroendocrine neoplasms exhibiting an increment in proliferative activity during the course of the disease.
Alexandraki KI; Kaltsatou M; Kyriakopoulos G; Mavroeidi V; Kostopoulou A; Atlan K; Theocharis S; Rindi G; Grossman AB; Grozinsky-Glasberg S; Kaltsas GA
Endocrine; 2021 Apr; 72(1):279-286. PubMed ID: 33175321
[TBL] [Abstract][Full Text] [Related]
28. Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors.
Taniguchi-Ponciano K; Andonegui-Elguera S; Peña-Martínez E; Silva-Román G; Vela-Patiño S; Gomez-Apo E; Chavez-Macias L; Vargas-Ortega G; Espinosa-de-Los-Monteros L; Gonzalez-Virla B; Perez C; Ferreira-Hermosillo A; Espinosa-Cardenas E; Ramirez-Renteria C; Sosa E; Lopez-Felix B; Guinto G; Marrero-Rodríguez D; Mercado M
Sci Rep; 2020 Nov; 10(1):19373. PubMed ID: 33168897
[TBL] [Abstract][Full Text] [Related]
29. Multiple Endocrine Neoplasia Type 1: Latest Insights.
Brandi ML; Agarwal SK; Perrier ND; Lines KE; Valk GD; Thakker RV
Endocr Rev; 2021 Mar; 42(2):133-170. PubMed ID: 33249439
[TBL] [Abstract][Full Text] [Related]
30. Thoracic nuclear protein in testis (NUT) carcinoma: expanded pathological spectrum with expression of thyroid transcription factor-1 and neuroendocrine markers.
Hung YP; Chen AL; Taylor MS; Huynh TG; Kem M; Selig MK; Nielsen GP; Lennerz JK; Azzoli CG; Dagogo-Jack I; Kradin RL; Mino-Kenudson M
Histopathology; 2021 May; 78(6):896-904. PubMed ID: 33231320
[TBL] [Abstract][Full Text] [Related]
31. Radiosynthesis of [
Lindner S; Wängler C; Bailey JJ; Jurkschat K; Bartenstein P; Wängler B; Schirrmacher R
Nat Protoc; 2020 Dec; 15(12):3827-3843. PubMed ID: 33230332
[TBL] [Abstract][Full Text] [Related]
32. Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters.
van Beek DJ; Nell S; Verkooijen HM; Borel Rinkes IHM; Valk GD; ; Vriens MR; ;
Surgery; 2021 Apr; 169(4):963-973. PubMed ID: 33220975
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic neuroendocrine tumor presenting in indolent systemic mastocytosis: A case report.
Sacco K; Khan TM; Passi M; Hernandez JM; Komarow H
Int J Surg Case Rep; 2020; 77():397-402. PubMed ID: 33220657
[TBL] [Abstract][Full Text] [Related]
34. Human pituitary development and application of iPSCs for pituitary disease.
Matsumoto R; Takahashi Y
Cell Mol Life Sci; 2021 Mar; 78(5):2069-2079. PubMed ID: 33206204
[TBL] [Abstract][Full Text] [Related]
35. Estrogen Receptors in Nonfunctioning Pituitary Neuroendocrine Tumors: Review on Expression and Gonadotroph Functions.
Haydar Ali Tajuddin A; Kamaruddin N; Sukor N; Azizan EA; Omar AM
J Endocr Soc; 2020 Dec; 4(12):bvaa157. PubMed ID: 33241169
[TBL] [Abstract][Full Text] [Related]
36. TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations.
Arita H; Matsushita Y; Machida R; Yamasaki K; Hata N; Ohno M; Yamaguchi S; Sasayama T; Tanaka S; Higuchi F; Iuchi T; Saito K; Kanamori M; Matsuda KI; Miyake Y; Tamura K; Tamai S; Nakamura T; Uda T; Okita Y; Fukai J; Sakamoto D; Hattori Y; Pareira ES; Hatae R; Ishi Y; Miyakita Y; Tanaka K; Takayanagi S; Otani R; Sakaida T; Kobayashi K; Saito R; Kurozumi K; Shofuda T; Nonaka M; Suzuki H; Shibuya M; Komori T; Sasaki H; Mizoguchi M; Kishima H; Nakada M; Sonoda Y; Tominaga T; Nagane M; Nishikawa R; Kanemura Y; Kuchiba A; Narita Y; Ichimura K
Acta Neuropathol Commun; 2020 Nov; 8(1):201. PubMed ID: 33228806
[TBL] [Abstract][Full Text] [Related]
37. Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment.
Busse A; Mochmann LH; Spenke C; Arsenic R; Briest F; Jöhrens K; Lammert H; Sipos B; Kühl AA; Wirtz R; Pavel M; Hummel M; Kaemmerer D; Baum RP; Grabowski P
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33228231
[TBL] [Abstract][Full Text] [Related]
38. Unique Metastatic Patterns in Neuroendocrine Neoplasms of Different Primary Origin.
Hermans BCM; de Vos-Geelen J; Derks JL; Latten L; Liem IH; van der Zwan JM; Speel EM; Dercksen MW; Dingemans AC
Neuroendocrinology; 2021; 111(11):1111-1120. PubMed ID: 33227805
[TBL] [Abstract][Full Text] [Related]
39. Dedifferentiated Endometrioid Carcinomas with Neuroendocrine Differentiation: A Clinicopathological and Immunohistochemical Study of Three Cases.
Zhou F; Zhang X; Chen H; Zheng W
Cancer Manag Res; 2020; 12():11623-11629. PubMed ID: 33223851
[TBL] [Abstract][Full Text] [Related]
40. Targeting histone deacetylases for combination therapies in neuroendocrine tumors.
Gagliano T; Brancolini C
Cancer Gene Ther; 2021 Jun; 28(6):547-550. PubMed ID: 33221822
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
